Routti Jorma 4
4 · FIBROGEN INC · Filed Aug 10, 2018
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Routti Jorma
Director
Transactions
- Sale
Common Stock
2018-08-09$60.36/sh−2,028$122,410→ 131,812 total - Sale
Common Stock
2018-08-09$61.21/sh−272$16,649→ 131,540 total - Sale
Common Stock
2018-08-09$59.60/sh−3,700$220,520→ 133,840 total - Exercise/Conversion
Common Stock
2018-08-09$18.00/sh+6,000$108,000→ 137,540 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-09−6,000→ 0 totalExercise: $18.00Exp: 2024-11-13→ Common Stock (6,000 underlying)
Footnotes (5)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $59.10 to $60.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The shares were sold at prices ranging from $60.10 to $60.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The shares were sold at prices ranging from $61.10 to $61.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Fully vested.